Kyriss T - Search Results

1

The toxic effects of cigarette additives. Philip Morris' project mix reconsidered: an analysis of documents released through litigation.

Wertz MS, Kyriss T, Paranjape S, Glantz SA. Wertz MS, et al. Among authors: kyriss t. PLoS Med. 2011 Dec;8(12):e1001145. doi: 10.1371/journal.pmed.1001145. Epub 2011 Dec 20. PLoS Med. 2011. PMID: 22205885 Free PMC article.

2

Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.

Tan CE, Kyriss T, Glantz SA. Tan CE, et al. Among authors: kyriss t. PLoS Med. 2013;10(5):e1001450. doi: 10.1371/journal.pmed.1001450. Epub 2013 May 28. PLoS Med. 2013. PMID: 23723740 Free PMC article.

3

The development of scientific consultants: how the tobacco industry creates controversy on the carcinogenicity of tobacco-specific nitrosamines.

Kyriss T, Schneider NK. Kyriss T, et al. Tob Control. 2013 May;22(3):e3. doi: 10.1136/tobaccocontrol-2012-050696. Epub 2012 Sep 2. Tob Control. 2013. PMID: 22940678

4

[Is passive smoking carcinogenic? German toxicologists and their link with the tobacco industry].

Kyriss T, Schneider NK. Kyriss T, et al. Neuere Med Wiss Quellen Stud. 2012;22:113-23. Neuere Med Wiss Quellen Stud. 2012. PMID: 22530497 German. No abstract available.

5

[The German cigarette industry association--obstructing effective tobacco control in Germany].

Kyriss T, Pötschke-Langer M, Grüning T. Kyriss T, et al. Gesundheitswesen. 2008 May;70(5):315-24. doi: 10.1055/s-2008-1078752. Gesundheitswesen. 2008. PMID: 18604770 German.

6

[Surgical curriculum. A model from thoracic surgery].

Kyriss T, Veit S, Friedel G, Kaiser D, Toomes H. Kyriss T, et al. Chirurg. 2005 Nov;76(11):1058-63. doi: 10.1007/s00104-005-1078-y. Chirurg. 2005. PMID: 16079967 German.

7

eComment: Swyer-James-MacLeod syndrome: addendum to the clinical appearance.

Walles T, Kyriss T, Maier AS, Friedel G. Walles T, et al. Among authors: kyriss t. Interact Cardiovasc Thorac Surg. 2009 Apr;8(4):484. doi: 10.1510/icvts.2008.197566A. Interact Cardiovasc Thorac Surg. 2009. PMID: 19304776 No abstract available.

8

Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.

Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G. Steger V, et al. Among authors: kyriss t. Ann Thorac Surg. 2009 Jun;87(6):1676-83. doi: 10.1016/j.athoracsur.2009.03.068. Ann Thorac Surg. 2009. PMID: 19463576

9

Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled, randomized phase IV study.

Kyriss T, Wurst H, Friedel G, Jaki R, Toomes H. Kyriss T, et al. Eur J Cardiothorac Surg. 2001 Jul;20(1):38-41. doi: 10.1016/s1010-7940(01)00762-x. Eur J Cardiothorac Surg. 2001. PMID: 11423271 Clinical Trial.

10

Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T. Friedel G, et al. Among authors: kyriss t. J Clin Oncol. 2010 Feb 20;28(6):942-8. doi: 10.1200/JCO.2008.21.7810. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100967 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results